dimiracetam dimiracetam dimiracetam is a nootropic drug of the racetam family, derivatives of which may have application in the treatment of neuropathic pain. dimiracetam names iupac name (rs)-3,6,7,7a-tetrahydro-1h-pyrroloimidazole-2,5-dione identifiers cas number 126100-97-8 y 3d model (jsmol) interactive imageinteractive image chembl chembl337612 y chemspider 59358 y pubchem cid 65955 unii 4aw7f70mzo y inchi inchi=1s/c6h8n2o2/c9-5-3-8-4(7-5)1-2-6(8)10/h4h,1-3h2,(h,7,9) ykey: xtxxohphlnrobn-uhfffaoysa-n yinchi=1/c6h8n2o2/c9-5-3-8-4(7-5)1-2-6(8)10/h4h,1-3h2,(h,7,9)key: xtxxohphlnrobn-uhfffaoyax smiles c1cc(=o)n2c1nc(=o)c2o=c2nc1n(c(=o)cc1)c2 properties chemical formula c6h8n2o2 molar mass 140.142 g·mol−1 pharmacology legal status au: s4 (prescription only) except where otherwise noted, data are given for materials in their standard state (at 25 °c , 100 kpa). y verify (what is yn ?) infobox references legality australia dimiracetam is a schedule 4 substance in australia under the poisons standard (february 2020). a schedule 4 substance is classified as "prescription only medicine, or prescription animal remedy – substances, the use or supply of which should be by or on the order of persons permitted by state or territory legislation to prescribe and should be available from a pharmacist on prescription."